News

GlaxoSmithKline (GSK) has entered into a partnership with the UK Government, The Wellcome Trust and the East of England Development Agency (EEDA), to develop a new biotechnology science

Metabolex, a biopharmaceutical company focused on the discovery and development of proprietary new medicines for the treatment of metabolic diseases, reported positive results from two multiple ascending dose

Provectus Pharmaceuticals (Provectus) has completed patient accrual and initial treatment in its phase 2 trial of PH-10 for the treatment of plaque psoriasis. This marks the third phase

FT4 Powder Rheometer from Freeman Technology is enabling organic chemists at Clarochem (Ireland), to incorporate some fundamental aspects of material science into their crystallization work. Reportedly, FT4 Powder

Merck KGaA’s wholly-owned subsidiary in India, Merck Specialities, has acquired Bangalore Genei (BGIP) from the Sanmar Group. BGIP is located in Bangalore and specialises in the development, production,

Perrigo Company (Perrigo) has filed an Abbreviated New Drug Application (ANDA) for over-the-counter (OTC) Minoxidil topical aerosol foam, 5%, a generic form of Men’s Rogaine Foam. Men’s Rogaine

US Patent and Trademark Office (USPTO) has issued a patent for the Champions Biotechnology’s (Champions) tubulin inhibitors, including its lead compound SG410. Reportedly, US Patent No. 7,595,326 entitled

The US Patent and Trademark Office (USPTO) has issued a notice of allowance to Medicis for its US patent application directed to the use of Solodyn (minocycline HCl,

Dyax has unveiled new developments involving drug candidates identified using the company’s phage display technology as a result of two deals recently announced by sanofi-aventis. Sanofi-aventis is planning